Top 20 Companies Market Driving Innovation in Prefilled Syringes Market 2025

The pharmaceutical and healthcare industries have witnessed significant advancements over the past few decades, with a strong focus on improving patient outcomes, enhancing convenience, and ensuring safety. Among the many innovations, prefilled syringes have emerged as a game-changer in drug delivery systems. Designed to enhance patient safety and reduce dosing errors, prefilled syringes eliminate the need for manual preparation, minimizing contamination risks and ensuring accurate drug delivery.

As the demand for self-administration and biologic drugs grows, pharmaceutical companies are increasingly adopting prefilled syringes for vaccines, biologics, and emergency medications. In this blog, we will explore the growing importance of prefilled syringes, their advantages, and the key companies leading the charge in this rapidly evolving market.

What are Prefilled Syringes?

Prefilled syringes are single-dose containers filled with a specific medication ready for administration. They are designed to eliminate the need for manual filling, reducing the risk of contamination and dosage errors. These syringes are widely used for vaccines, biologics, and other injectable drugs, and subcutaneous drug delivery, particularly in therapeutic areas such as diabetes, autoimmune disease, and oncology.

The design of prefilled syringes typically includes a glass or plastic barrel, a plunger, and a needle or needless system. They are available in various sizes and configurations, catering to different drug formulations and patient needs. The convenience, accuracy, and safety they offer have made them a preferred choice for both healthcare professionals and patients.

Factors Influencing Prefilled Syringes Market

The global prefilled syringes market has experienced robust growth in recent years, driven by the improving demand for biologics, human and animal vaccines, and self-administration devices.

• Rising Prevalence of Chronic Diseases

The growing prevalence of chronic illnesses and the increasing use of self-administered biologics for chronic illnesses, including diabetes and autoimmune diseases, with the help of prefilled syringes, are expected to increase global demand. Prefilled syringes help patients take their medication regularly and correctly, which improves treatment outcomes. These diseases often require regular injections, which prefilled syringes provide a safe and convenient way to manage. Prefilled syringes reduce the risk of dosage errors, which can be harmful to patients.

• Expansion of Biologics

The prefilled syringe market is rapidly expanding due to the growing demand for biologics, as most biologics are administered via injection, and prefilled syringes offer a convenient and accurate delivery method, driving significant market growth with advancements in self-administration technologies like autoinjectors and increasing adoption of biologics for chronic conditions requiring repeated injections.

• Technological Advancements

Innovations in materials, such as cyclic olefin polymers (COP) and cyclic olefin copolymers (COC), have improved the performance and compatibility of prefilled syringes with a wider range of drug formulations. Prefilled syringes are expected to become safer, more affordable, and easier to use thanks to continuous developments in materials science. Polymer syringes or those with multi-dose capabilities are examples of innovations that could reach a larger audience and significantly expand the market.

Key Companies Offering Prefilled Syringes

1. Becton, Dickinson, and Company (BD)

Established: 1897 (East Rutherford, New Jersey, USA)

Headquarters: Franklin Lakes, New Jersey, USA

Key Product: BD Hypak, BD Neopak

BD is a medical technology company that produces and sells medical equipment, systems, and reagents. BD is a global leader in medical technology and a pioneer in the development of prefilled syringes. The company offers a comprehensive portfolio of prefilled syringe systems, including glass and plastic options, designed to meet the needs of drug manufacturers and healthcare providers. The company provides customized PFS solutions for vaccines, insulin, and biologics.

2. Nipro Corporation

Established: 1954

Headquarters: Osaka, Japan

Key Product: Nipro ClearJect Polymer Syringes

Nipro Corporation is a Japanese multinational company specializing in medical devices and pharmaceutical packaging. The company was originally called Nihon Glass Shoji Co. Ltd. and sold glass tubing for ampoules and pill bottles. The company's prefilled syringes are widely used for vaccines, insulin, and other injectable therapies. Nipro's commitment to quality and innovation has earned it a strong reputation across the globe. BD has manufacturing operations in many countries, including the US, Canada, Brazil, and India.

3. Schott AG

Established: 1884

Headquarters: Mainz, Germany

Key Products: SCHOTT TOPPAC and syriQ

Schott is a renowned supplier of specialty glass and pharmaceutical packaging solutions. Schott is a renowned supplier of specialty glass and pharmaceutical packaging solutions. The company's prefilled syringes, made from borosilicate glass, are known for their exceptional clarity, chemical resistance, and durability. Schott AG is a leading producer of glass and polymer PFS with superior barrier properties.

4. Stevenato Group

Established: 1949

Headquarters: Piombino Dese, Italy

Key Products: EZ-fill Syringes

Stevanato Group is a leading provider of drug containment and delivery solutions, including prefilled syringes. The company manufactures highly customizable, pre-sterilized PFS for large-scale drug manufacturers. They are also the first worldwide producer of insulin cartridges for diabetes treatment. The company's EZ-fill platform offers ready-to-use glass syringes that are ideal for biologics and high-value drugs.

5. West Pharmaceutical Services

Established: 1923

Headquarters: Exton, Pennsylvania, USA

Key Product: NovaGuard Safety System

West Pharmaceutical Services is a manufacturer and designer of injectable drug delivery and packaging systems. The company has expertise in injection molding, contract assembly, and finished packaging. Its prefilled syringes, including the NovaPure®and Daikyo Crystal Zenith platforms, are designed to enhance drug stability and patient safety.

Future Outlook

The future outlook for prefilled syringes is positive, with a projected significant market growth driven by increasing demand for convenient and safe drug delivery, particularly for chronic diseases, coupled with advancements in design and technology that enhance patient usability and reduce medication errors. In the upcoming years, we can expect to see further innovations in materials, designs, and functionalities, such as smart syringes with integrated sensors for dose tracking and monitoring. This includes the development of smart features and improved needle safety mechanisms. As the market continues to grow, prefilled syringes will play an increasingly important role in improving patient outcomes and addressing the challenges of modern medicine.